Company intelligence / Profile preview

ACTO

Toronto, Ontario, Canada

Ownership: Private
Development stage: Other

Overview

ACTO provides an AI-powered platform that supports field training, sales effectiveness, and compliance for life sciences (pharma, biotech, and medical device) companies. It empowers commercial and medical teams with tools for clinical education, product messaging, and HCP engagement but does not itself develop pharmaceutical products or clinical-stage therapeutics.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Veeva (AI Partner, Silver Product Partner)

Beyond the preview

Go deeper on ACTO.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ACTO.

Explore the full profile